India, Feb. 20 -- While reporting financial results for the fourth quarter on Thursday, health care company Baxter International Inc. (BAX) initiated its earnings, adjusted earnings and sales growth guidance for the first quarter and for the full-year 2025. For the first quarter, the company anticipates adjusted earnings from continuing operations in a range of $0.47 to $0.50 per share on sales growth from continuing operations of 3 to 4 percent on a reported basis, with approximately 4 percent on an operational basis.
On average, analysts polled expect the company to report earnings of $0.49 per share on a revenue decline of 26.87 percent to $2.63 billion for the quarter. Analysts' estimates typically exclude special items.
Looking ahead...